Alkermes Plc (ALKS)
49.17
-0.04
(-0.08%)
USD |
NASDAQ |
Aug 26, 16:00
49.17
0.00 (0.00%)
After-Hours: 17:05
Alkermes Price : 49.17 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 48.94 | 49.58 | 48.87 | 49.21 | 1.127M |
| Aug 24, 2026 | 48.05 | 49.03 | 47.64 | 48.87 | 1.297M |
| Aug 21, 2026 | 48.05 | 48.67 | 47.33 | 48.33 | 939640.0 |
| Aug 20, 2026 | 49.37 | 49.86 | 47.93 | 48.02 | 1.635M |
| Aug 19, 2026 | 51.26 | 51.29 | 50.08 | 50.18 | 1.544M |
| Aug 18, 2026 | 50.10 | 50.42 | 49.46 | 49.48 | 970918.0 |
| Aug 17, 2026 | 48.90 | 50.08 | 48.62 | 49.85 | 764041.0 |
| Aug 14, 2026 | 49.37 | 50.02 | 48.65 | 49.06 | 1.268M |
| Aug 13, 2026 | 51.66 | 51.66 | 49.21 | 49.45 | 1.547M |
| Aug 12, 2026 | 49.22 | 50.53 | 48.50 | 50.28 | 1.316M |
| Aug 11, 2026 | 49.92 | 50.14 | 48.97 | 49.21 | 1.374M |
| Aug 10, 2026 | 48.39 | 49.81 | 48.39 | 49.40 | 1.511M |
| Aug 07, 2026 | 49.05 | 49.90 | 48.67 | 49.17 | 1.111M |
| Aug 06, 2026 | 49.61 | 50.40 | 48.21 | 48.37 | 1.569M |
| Aug 05, 2026 | 50.20 | 50.85 | 49.23 | 49.61 | 1.707M |
| Aug 04, 2026 | 49.73 | 50.36 | 49.00 | 49.67 | 1.431M |
| Aug 03, 2026 | 48.58 | 50.70 | 48.19 | 49.53 | 1.836M |
| Jul 31, 2026 | 49.63 | 49.83 | 48.52 | 48.99 | 1.624M |
| Jul 30, 2026 | 47.85 | 50.34 | 47.71 | 50.03 | 2.303M |
| Jul 29, 2026 | 50.50 | 50.72 | 47.66 | 48.34 | 4.150M |
| Jul 28, 2026 | 50.42 | 52.51 | 49.33 | 50.50 | 2.876M |
| Jul 27, 2026 | 52.87 | 53.84 | 52.48 | 52.73 | 1.403M |
| Jul 24, 2026 | 53.38 | 53.88 | 52.48 | 52.89 | 1.289M |
| Jul 23, 2026 | 52.13 | 53.54 | 51.68 | 52.97 | 1.488M |
| Jul 22, 2026 | 52.55 | 53.27 | 52.35 | 52.58 | 1.837M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amarin Corp. Plc | 14.38 |
| Jazz Pharmaceuticals Plc | 249.40 |
| Prothena Corp. Plc | 9.265 |
| ACADIA Pharmaceuticals, Inc. | 29.57 |
| Biogen, Inc. | 221.12 |
Price Related Metrics
| PE Ratio | 127.71 |
| PS Ratio | 4.996 |
| Price to Book Value | 4.555 |
| Price to Free Cash Flow | 37.59 |
| Earnings Yield | 0.78% |
| Market Cap | 8.238B |
| Operating PE Ratio | 57.99 |
| Normalized PE Ratio | 100.02 |